Chinese patent medicine for treating primary lung cancers

Abstract

A Chinese patent medicine for treating primary lung cancers is characterized by being prepared from, by weight, 27-33 parts of cornu saigae tatariace powder, 27-33 parts of semen descurainiae, 27-33 parts of bulbus fritillariae cirrhosae, 5-7 parts of flos daturae, 27-33 parts of radix ranunculi ternati, 27-33 parts of radix semiaquilegiae, 18-22 parts of bryozoatum, 18-22 parts of radix notoginseng, 27-33 parts of parched pangolin scales, 27-33 parts of radix trichosanthis, 27-33 parts of honeysuckle and 27-33 parts of radix sophorae subprostratae. The raw materials in the weight proportion are made into the Chinese patent medicine for oral administration.

Description

technical field [0001] The invention relates to a medicine for treating primary lung cancer, in particular to a Chinese patent medicine for treating primary lung cancer prepared from Chinese herbal medicines. Background technique [0002] Primary lung cancer is referred to as lung cancer, which belongs to the categories of "lung accumulation", "breathing cardia", "lung pain", "cough", "chest pain" and "hemoptysis" in traditional Chinese medicine. In recent years, the morbidity and mortality of countries all over the world have risen sharply, especially in developed countries such as the United States, France, Japan, and Britain. The disease occurs between the ages of 45 and 75, and the ratio of male to female is 2:1. According to the survey, lung cancer ranks fourth in male malignant tumors and fifth in females. Now it has become a serious threat to human life and health. One of the common diseases. [0003] At present, Western medicine mainly adopts surgery, radiotherapy,...